Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08) (English, HTML)
Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08): English HTML file. From Health Canada, updated Oct 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-10-01
The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate, fedratinib, lefamulin, obiltoxaximab, polatuzumab vedotin, ripretinib, satralizumab and sonidegib to the Prescription Drug List (PDL) for human and/or veterinary use.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file